Maternal COVID-19 Vaccination Highly Effective for Infants
Highly effective against delta, moderately effective against omicron infection and hospital admission in infants
Immunization Schedule for Children, Teens Updated for 2023
Changes to 2023 schedule include addition of new row for COVID-19, recommending vaccination for those aged 6 months to 18 years
Pegylated Interferon Lambda Effective in Preventing Severe COVID-19
Incidence of hospitalization or emergency department visit lower for those receiving interferon versus placebo
Surge in Severe Strep Cases in Children Was Really a Return to Normal: CDC
As with other early infections in recent months, including RSV and flu, invasive group A streptococcal cases were reported earlier in the season than is typical
Rhinoviruses, Enteroviruses Persisted During Pandemic Among Pediatric Patients
From October 2020 to February 2021, rhinoviruses and/or enteroviruses detected at same or higher odds than in prepandemic months
Maternal Tdap Vaccination Protects Youngest Infants From Pertussis
Incidence of pertussis decreased among infants younger than 2 months after maternal Tdap vaccination implementation
Pre-Infection Healthy Lifestyle Tied to Lower Risk for Long COVID
Healthy body mass index and adequate nightly sleep showed highest preventive benefit
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
Vaccine effectiveness against death was lower for patients aged 80 years and older
More Than 400 Snacks, Sandwiches Recalled Over Listeria Concerns
Products recalled after environmental samples tested positive for L. monocytogenes; no reports of illness so far
COVID-19 Vaccine Primary Series Coverage 76 Percent in Adults 60 Years and Older
Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations
